Personalized weight loss services
About Our Program
Welcome to our comprehensive medical weight loss program. We understand the challenges of achieving and maintaining a healthy weight, which is why we’ve developed an evidence-based approach to help you reach your goals.
Supportive Environment
We believe that weight loss is not just about the physical transformation, but also the emotional and mental well-being of our patients. That’s why we strive to create a supportive and nurturing environment where you can feel comfortable and empowered throughout your journey.
Obesity is a complex disease, not simply a matter of willpower. Our weight loss services are designed to address the whole person, not just the number on the scale. We take a holistic approach that considers your overall health, lifestyle, and personal goals. By addressing the root causes of weight gain, we can help you achieve lasting results and improve your quality of life.
Incretin-based therapies are a class of medications used to treat type 2 diabetes and obesity. They work by mimicking the actions of natural incretin hormones, such as glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) which help regulate blood sugar levels. Medications like GLP-1/GIP agonists can be very helpful tools, but need to be part of a holistic approach to achieve sustained weight loss and health benefits. The key benefits of GLP-1 and dual GLP-1/GIP agonists for weight loss are their ability to suppress appetite, reduce food intake, and produce significant weight loss - especially when combined with lifestyle changes. However, they are not a standalone solution and work best as part of a comprehensive weight management program. GLP-1 agonists like semaglutide and tirzepatide (a dual GLP-1/GIP agonist) have been shown to provide significant weight loss benefits. They help suppress appetite and reduce food intake by:
Stimulating insulin secretion and suppressing glucagon, which regulates blood sugar levels
Delaying gastric emptying to increase feelings of fullness
They can produce profound weight loss, often in combination with diet and lifestyle changes
The dual GLP-1/GIP agonist tirzepatide appears to enhance the weight loss effects compared to GLP-1 agonists alone
The most successful outcomes occur when the medications are combined with a comprehensive weight management program, dietary changes, regular exercise and addressing underlying mental/physiological factors that contribute to obesity.
Obesity is a chronic condition, similar to hypertension and heart disease, and therefore can require medication maintenance to manage it. Though GLP-1 agonists and GIP agonists are intended for long-term use to manage obesity as a chronic condition, patients may be able to maintain their weight loss even after discontinuing the medication, especially if they combine it with a comprehensive weight loss program and exercise. The duration of treatment needed to maintain weight loss can vary between individuals.
Who is a candidate for GLP-1 agonist and GLP-1 agonist and GIP agonist medication for weight loss?
Those with a Body Mass Index (BMI) > 30 kg/m2 or those with a BMI of > 27 kg/m2 with weight-related comorbidities.
Schedule a Consultation
If you’re ready to take the first step towards a healthier, more confident you, we invite you to schedule a consultation with one of our Family Nurse Practitioners. Our providers have over 15 years combined experience in managing diabetes and obesity and possess expertise in addressing the physiological basis of obesity, nutrition, physical activity, and behavior modification. During your appointment, we’ll discuss your goals, assess your current health status, and develop a personalized plan to help you reach your desired weight and maintain it long-term.
